Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhanced Diuresis and Natriuresis in Acute Decompensated Heart Failure Patients Treated With SGLT-2 Inhibitor and High-Dose Furosemide Plus Small-Volume Hypertonic Saline Solution: A Clinical Trial

NCT06442280 is registered in ClinicalTrials.gov with University of Palermo as lead sponsor.

NCT NCT06442280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06442280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhanced Diuresis and Natriuresis in Acute Decompensated Heart Failure Patients Treated With SGLT-2 Inhibitor and High-Dose Furosemide Plus Small-Volume Hypertonic Saline Solution: A Clinical Trial
Lead sponsor
University of Palermo
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2024
Completion date
March 30, 2026
Enrollment
544 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes type 2, heart failure acute, heart failure with preserved ejection fraction, heart failure with reduced ejection fraction